IDEX Corporation acquired thinXXS Microtechnology AG for $38.2 million (cash) plus $1.2M assumed debt, a transaction completed in December 2017, structured as all cash (stock acquisition).
thinXXS Microtechnology AG operates in Health & Science Technologies, is based in Zweibrucken, Germany. Leader in the design, manufacture and sale of microfluidic components serving the point-of-care, veterinary and life science markets. Headquartered in Zweibrucken, Germany.
Complements existing CiDRA Precision Services business and expands microfluidic and nanofluidic capabilities. Health & Science Technologies segment
On December 8, 2017, the Company acquired the stock of thinXXS Microtechnology AG (“thinXXS”), a leader in the design, manufacture, and sale of microfluidic components serving the point of care, veterinary, and life science markets.
Advisory firms were not disclosed for this transaction.